2X Match My Gift
Make a tax-deductible donation and double your impact to support colorectal cancer patients, survivors, and caregivers.
Cases of young-onset colorectal cancer (YO-CRC) are increasing, but there's more to know about how this disease affects people under age 50.
About 10% of CRCs appear in people under age 50.
YO-CRC could be the deadliest cancer by 2030 in people 20-49.
Since 1994, cases of YO-CRC have increased by 51 percent.
Rectal cancer is more common than colon cancer in young patients.
Delays in diagnosis occur in 15-50% of young-onset cases.
The age people at average risk should start getting checked.
The incidence of young-onset colorectal cancer has been rising, contrary to the declining rates in older adults.
Young-onset colorectal cancer is often diagnosed at more advanced stages, which may be due to delayed recognition of symptoms and screening.
Symptoms are similar to colorectal cancer in older adults, including changes in bowel habits, abdominal pain, and rectal bleeding.
Risk factors may include family history of colorectal cancer, genetic mutations, and certain hereditary conditions.
Many young-onset colorectal cancer cases have a genetic component, making genetic counseling and testing important for patients and families.
Treatment options are similar to those for older adults, including surgery, chemotherapy, and radiation, but issues like fertility may impact treatment decisions.
Treatments may affect fertility, so it's important for young patients to discuss fertility preservation options with their medical team.
Young-onset colorectal cancer can have a significant psychosocial impact, including challenges related to career, family, and emotional well-being.
Healthy lifestyle choices, including diet and physical activity, are important for prevention and recovery.
The Alliance's latest survey report of YO-CRC patients can help you understand more about what this group faces before, during, and after a diagnosis.
This year was the Alliance’s 25th year of impact, and we’re looking back on some of the milestones that made 2024 a year to remember.
The Colorectal Cancer Alliance’s national Blue Hope Bash, held November 2 at the National Building Museum in Washington, D.C., raised nearly $2 million to support lifesaving work.
Colorectal cancer patient Mark Bassett won a Porsche in the Blue Hope Bash car raffle, bringing unexpected joy and new experiences amid his cancer journey.